Our findings suggest that DLEU1-mediated stabilization of DYNLL1 is critical for cell survival and that the DLEU1/DYNLL1 axis may be a promising therapeutic target for ESCC. The gene discussed is DLEU1; the disease is esophageal squamous cell carcinoma.